1.
OVERVIEW OF INFECTIOUS-DISEASE INFORMATION
Below is a semi-monthly summary of Asia-Pacific emerging infectious diseases.
ASIA
East Asia: Avian influenza, latest updates, 34
confirmed cases, 23 deaths
Viet Nam — Declares avian influenza
over; new regulations in Ho Chi Minh
Viet Nam declared
an end to its bird flu crisis — over the objections
of the World Health Organization (WHO) and the Food and Agriculture
Organization (FAO) — after one month of no new recorded
outbreaks. Agriculture Minister Le Huy Ngo made the announcement
at a meeting on Tuesday last week, three months after the first
cases hit Viet Nam. Ngo said the country would lift the bans
on the transport, processing, and consumption of poultry across
the country. The meeting heard reports that about 40 million
poultry, or 15 per cent of the country's stocks, were killed
or culled across the country, with almost half coming from
the Cuu Long (Mekong) Delta provinces. The poultry industry's
losses are estimated at USD 190 million. Ngo said the State
would give affected farmers VND 5000 (USD 0.32) per culled
bird, VND 2000 (USD 0.13) per breeding stock, with total state
assistance coming to USD 13.73 million.
Ho Chi Minh City banned 6 Apr 2004 the sale of
live poultry in urban markets to prevent a recurrence of the
epidemic. City authorities also issued regulations requiring
that slaughter take place only at government-approved facilities,
which must be located away from the densest part of the city.
Ho Chi Minh is also reportedly planning to build two or three
large slaughterhouses to meet demand. The country's new rules
stipulate that all birds be certified by veterinary inspectors
prior to being sold, but the FAO questioned Viet Nam's ability
to enforce the order. WHO, meanwhile, voiced fears that Viet
Nam was putting its poultry industry ahead of public health.
Bird flu killed 16 people in Viet Nam in this outbreak, more
than in any other country.
(Promed
4/7/04)
Thailand — New bird-flu measures
announced
In order to prevent the spread of avian influenza
after chicken farming resumes on a mass scale, the Livestock Department
announced measures to continue controlling the movement of chickens.
Livestock Department director-general Yukol Limlaemthong said that
the department recently issued an announcement designating Thailand
as a suspected bird-flu epidemic zone — all provincial governors
are being advised to limit the movement of chickens in their jurisdiction.
After four months of the epidemic, farmers have sought permission
to resume raising chickens. Yukol said it would not be possible
to raise large numbers of chickens at many farms at the same time
as some areas are still under surveillance, even though they have
met the 21-day period required by the International Office of Epizootics
(OIE). The department said it needed to further monitor the areas
for three months, at the request of chicken importers.
(Promed 3/30/04)
Thailand —Poultry industry to restock
The
Thai poultry industry could be about to restock on a massive scale
after the devastation of the avian flu epidemic earlier this year.
The country's feed industry is set to import cargoes of Argentine
soybeans as the country prepares to declare itself free of the
virus. Thailand is also looking to soymeal cargoes from India.
The decimation of the poultry sector in Thailand, which accounts
for more than half of commercial feed consumption, has resulted
in a steep decline in feed demand, but this looks set to change.
The Thai government is expected to declare by the end of the week
that the outbreak is over. The country, whose poultry export business
annually tops USD 1 billion, has been forced to cull over 25 million
chickens, and like other counties stricken by the deadly virus,
the country is desperate to restore its poultry industry.
The UN's FAO has warned that
countries affected by the deadly avian influenza virus H5N1 should
not restock their flocks too quickly to avoid the disease flaring
up again. The FAO says that before restocking, countries must prove
the absence of virus circulation by virus research, serological
surveys and the use of non-vaccinated susceptible chickens (sentinels)
on infected sites to test whether they become infected.
(Promed 4/7/04)
Britain: NIBSC Wins Race to Genetically
Engineer H5N1 Vaccine Strain
A British government laboratory
has genetically engineered a safe version of the avian influenza
A (H5N1) virus to use as the basis of a vaccine, beating out the
CDC and St. Jude Children's Research Hospital, who were pursuing
the same goal. The achievement by the National Institute for Biological
Standards and Controls (NIBSC) in London will be announced next week
by the WHO. WHO is overseeing the research, which aims to create
a vaccine against avian influenza A (H5N1) virus as insurance in
case the disease begins to spread rapidly among people.
All three labs were trying to create a new virus using reverse
genetics. The first step was to insert two genetic components,
the H5 and N1 encoding subunits, from the H5N1 avian flu virus
into a benign flu virus commonly used in labs. The second step
was to grow the new virus in pure cell lines that would be acceptable
to regulatory authorities, including the U.S. Food and Drug Administration.
That was to be followed by safety-testing the reproduced virus
on chickens and ferrets to prove that its virulent qualities were
removed, the final hurdle before the new viral strain could be
released to manufacturers. The new strain will be given to manufacturers
next week when the official announcement is made.
(Promed 4/3/04)
South Korea — Lapses in screening
of donated blood (hepatitis C)
South Korea 's Red Cross
mishandled donor information and circulated blood donated by hepatitis
virus carriers, infecting nine people, government auditors said 29
Mar 2004 . The Board of Audit and Inspection (BAI) called on the
Korea National Red Cross to punish officials responsible for shipping
blood donated by hepatitis virus carriers to hospitals and pharmaceutical
companies for five years up until Jan 2004. A BAI audit conducted
at the end of 2003 found that 76,677 units of blood received from
donors who had been infected with hepatitis C virus had been distributed
for transfusions or research by the Red Cross. South Korea ’s
Red Cross also put into circulation 228 units of blood donated by
99 people who had been suspected of carrying human immunodeficiency
virus (HIV), but who later tested negative for the virus, an official
said. Nine people were found to have been infected with hepatitis
C virus during February 2004 after receiving blood transfusions from
the Red Cross.
South Korean Red Cross spokesman Lee Jae-sung said the problems
stemmed from a change in laws in Apr 2000 that banned donations
from people who had been infected with hepatitis. The previous
law had allowed donations from people who were hepatitis-free at
the time they gave blood. It was not immediately clear whether
there were also cases of hepatitis infections through blood donations
made before Apr 2000 under the earlier rules. "We changed
the rules for donation, but we only acquired a system to investigate
donors' disease history in May 2003," Lee said. "The
9 people infected with hepatitis C virus received blood during
the period between 1 Apr 2000 and May 2003," he said.
(Promed 3/30/04)
China (Hong Kong) — Ciguatera
fish poisoning
The number of people falling ill from a marine
toxin rose by eight cases. In the past three days, 53 people have
been sickened by ciguatoxin — a poison that occurs naturally
in some tropical fish. All patients have been released from hospital.
The toxins are known to originate from several dinoflagellate (algae)
species that are common to ciguatera endemic regions. The Food and
Environmental Hygiene Department said it is considering amending
the law to increase the number of tests for the toxin on imported
fish. Department director Gregory Leung said suppliers currently
provide small quantities of reef fish for testing by the government;
he did not say whether the planned changes would mean that testing
would be made compulsory.
One fish supplier in Kwun Tong voluntarily destroyed 2,000 fish
and recalled six tons of the fish from retailers after suspicions
were raised that stocks were contaminated. Leung urged the public
to avoid eating big reef fish altogether — larger fish are
thought to carry higher amounts of the toxin. Previously they were
merely warned to avoid eating the internal organs of fish — the
toxin usually accumulates in the liver and gonads. People were
also told to avoid drinking alcohol or eating nuts together with
the fish, because the combination can exacerbate the effects of
the poisoning. The toxin cannot be destroyed by cooking
Clinical testing procedures are not presently available for the
diagnosis of ciguatera in humans. Diagnosis is based on symptomatology
and recent dietary history. The main symptoms are numbness of the
mouth and limbs, vomiting, diarrhoea, hot and cold flushes, and
aching joints and muscles. While symptoms usually subside after
a few days, in severe cases the neurological symptoms can persist
for months or even years. In some cases, patients can suffer relapses
years after their recovery. There is a low incidence of death from
ciguatera fish poisoning.
(Promed 4/1/04)
Russia (Omsk and
Amur)—Measles outbreaks in Saratovo (Omsk)
and Blagoveshensk (Amur)
After an interval
of three years, there has been a resurgence of measles in the city
of Saratovo. Thirteen cases of measles were recorded during 2003,
but 40 cases of measles have been recorded during the first three
months of 2004. Of those infected, 88 percent are adults between
the ages of 20 and 40. None had suffered measles previously or had
been vaccinated. In 2004, mass immunization of adults up to 35 years
of age is planned. Immunization will be restricted to those who have
never had measles or to those who have not been vaccinated previously.
Nineteen cases of measles had been recorded in
Blagoveshensk by the end of March 2004. As of 5 Apr 2004, 29 cases
of measles had been admitted to hospital in Blagoveshensk. Most
of the cases are either students at the Amurskaya State Medical
Academy or at a local high school, but one case is a child under
the age of one. Preventive measures are being carried out in the
outbreak area. A quarantine regime has been established at the
Amurskaya State Medical Academy. (Promed 4/6/04)
Russia (Tulskaya Oblast) — Hemorrhagic
fever cases increase in frequency
Public health physicians
in the Tulskaya Oblast are warning the public that hemorrhagic
fever cases are becoming more frequent — 26 cases of hemorrhagic
fever have been reported in Tula (capital of Tulskaya Oblast)
since the beginning of 2004. The vectors of hemorrhagic fever
with renal syndrome are rodents, which begin
to increase in the spring. This year rodent numbers
have increased
5- to 10-fold, possibly due to the gap of two years
in the allocation of funds for rodent control. The
main carrier of the infection is the gray rat, but cats, dogs,
foxes,wolves, and other animals can become infected
by killing and consuming virus-carrying rodents,
which do not themselves exhibit signs of illness.The
virus is transmitted to humans through contact
with rodent excreta and detritus; little or no person-to-person
transmission occurs. (Promed 3/26/04)
Australia: Ross River fever
alert for southeastern Queensland
An
alarming outbreak of Ross River fever across southeastern Queensland
prompted a health authority warning for holiday-makers to
protect themselves this Easter. The 953 cases of the mosquito-borne
virus already reported to Queensland Health in 2004 were well up
on the same period of 2004. In 2002, just 886 cases were reported,
attributed to drought conditions. However, 2003 was significantly
worse, with 2,516 cases reported statewide. Authorities blamed
heavy rainfall in the past 4-6 weeks for the increase, although
they also said that increased awareness and testing may have
pushed figures up recently. The southeast corner has been hardest
hit, with north and southwest Queensland also reporting a sharp
increase in cases in recent weeks.
Ross River virus is endemic in most coastal regions of Australia
and since the 1980's appears to have extended its geographical
range to include most of the island communities of the South Pacific.
No cure is available, only prevention through measures such as
mosquito repellent, fly screens, and covering up exposed skin.
Residents have been urged to control mosquito breeding around homes.
Only 25 to 45 percent of Ross River fever victims suffer symptoms,
though for those who do, they can be debilitating. Symptoms include
fever, pain, swelling of the joints, and a red rash affecting the
trunk and limbs. Joint pain can last up to six weeks, though victims
usually take 4-7 months to fully recover. Fortunately illness is
not fatal and recovery is complete.
(Promed 4/3/04)
AMERICA
Canada (British Columbia) — Avian
influenza A (H7) virus human infections
The first human
case of avian influenza A (H7) virus infection in British Columbia
arose in a person who was involved in the culling of infected birds
on 13-14 Mar 2004. On 16 Mar, he reported conjunctivitis and nasal
discharge. Treatment with oseltamivir, an antiviral drug active against
influenza A viruses, began on 18 Mar. On 30 Mar, Health Canada concluded
that this case was caused by avian influenza A (H7) virus and informed
WHO on 31 Mar. The patient has recovered fully. On 2 Apr 2004, WHO
was informed by Health Canada of a second poultry worker in British
Columbia infected with avian influenza A (H7) virus infection. This
worker developed conjunctivitis on 25 Mar after close contact with
infected birds. He was treated with oseltamivir on 25 Mar, and his
symptoms resolved.
Based on this epidemiological information, WHO raised the global
pandemic preparedness level from 0.1 to 0.2 for the Canadian outbreak.
Global pandemic preparedness levels are dictated by the epidemiological
situation for each local event. Level 0.2 means that more than
one human case caused by a new subtype of influenza virus has been
identified in the local event. The existing global preparedness
level of 0.2 for the avian influenza in Asia remains unchanged.
When a preparedness level is raised to 0.2, affected countries
are advised to step up their surveillance in people exposed to
affected poultry, to organize special investigations to better
understand the new virus, to advise people at risk to wear protected
clothing, and to consider the use of antivirals and normal human
influenza vaccine. The new preparedness level for avian influenza
A (H7) also means that WHO will begin a series of activities to
obtain the virus, characterize it, and assess the needs for diagnostics
and vaccine development. In addition, the Canadian Food Inspection
Agency (CFIA) ordered the culling of 19 million domesticated fowl.
The order will have an impact on 80 percent of British Columbia
's chicken and turkey producers.
(Promed 4/6/04, 4/7/04)
Canada (British
Columbia) — WHO
starts developing human vaccine to BC avian flu strain
The
WHO is starting the process of producing a human vaccine for
the H7 avian flu virus ravaging poultry stocks in British Columbia,
and Canada's National Microbiology Laboratory will be one of
the centers working on the project. Dr Frank Plummer, the lab's
scientific director, confirmed that the lab will try to develop
a viral seed — a genetically modified version of the H7 virus
that could be used by commercial vaccine makers should the H7 strain
emerge as a pandemic strain. That possibility appears unlikely
at this point, but nevertheless health authorities have to prepare
for the possibility. It's also good practice for when the next
pandemic — believed by influenza experts to be inevitable — comes,
Plummer said. Producing a seed vaccine for an H7 virus requires
the capacity to use reverse genetics, a procedure in which the
part of the virus, which is deadly to chickens, is plucked out.
Vaccines are grown in fertilized eggs; unless an H7 virus is modified,
it would kill the embryos and arrest the process. If all goes well
the process should take between four and six weeks, Plummer said.
Plummer confirmed that the national lab would provide WHO with
samples of the viruses taken from the two people who were infected
with the H7 virus in British Columbia. WHO pandemic planning guidelines
require the organization to commence production on a human vaccine
for an avian influenza strain once there is evidence two people
have been infected in an outbreak. The H7 strain hasn't proved
to be as serious a threat to human health as the H5N1 strain, though
one person died in a large H7 outbreak in the Netherlands in the
spring of 2003 during which at least 89 people were infected. The
Dutch outbreak was caused by an H7N7 strain. The two Canadian cases
are believed to be an H7N3 strain.
(Promed 4/7/04)
USA (Oklahoma/Texas) — 66 tested
positive for Legionnaires' bacterium
A bacterium that
is connected to Legionnaires' disease has been confirmed in Oklahoma,
and state health officials said 22 Mar 2004 that an Oklahoma
hotel was the likely source. Approximately 70 players, parents,
and others stayed at the Oklahoma City hotel last week during
a basketball conference. The state Health Department and the
Oklahoma City-County Health Department said that the bacterium Legionella
pneumophila caused several upper respiratory illnesses among
people who stayed in the hotel. Officials said that 66 people from
Texas tested positive for the bacterium; 13 people from Houston
developed upper respiratory illnesses. The city-county health department
shut down the pool and spa where the outbreak is thought to have
started, and the department is trying to reach everyone who stayed
in the hotel recently.
The bacterium can lead to Legionnaires' disease, a severe infection
that includes pneumonia. Most who succumb have other weakening
conditions such as cancer, heart or lung illness, or extreme diabetes.
The bacterium can also cause a milder illness called Pontiac fever,
which usually passes after a few days and does not involve pneumonia.
Officials said two Houston residents were in the hospital with
Pontiac fever 22 Mar 2004. Both illnesses are treatable with antibiotics
and neither is contagious. The bacteria are spread through such
means as heated water and moisture in air conditioning ducts.
(Promed 3/23/04)
USA (Montana) — Sixth
death in the state caused by hantavirus infection
Hantavirus
has claimed another victim in northern Montana. The Glacier
National Park's Deputy Superintendent, 61, became ill with flu-like
symptoms in mid-March and died 25 Mar 2004. Blood tests confirmed
hantavirus infection, said Elaine Sedlack, a nurse with the Flathead
City-County Health Department. This is the 23rd case of hantavirus
pulmonary syndrome reported in Montana since 1993 and the sixth
death the state has reported. Officials are still investigating
how the deputy superintendent contracted the disease.
Hantavirus infection is contracted by inhaling airborne particles
from dried droppings, urine and saliva of infected deer mice. Rick
Douglass, a hantavirus researcher said, "You absolutely have
to mouse-proof your house. That includes filling any holes on the
outside of your home's foundation that you can place your finger
into. If you encounter any mouse droppings or urine, clean it up
using one part chlorine bleach to 10 parts water; wear latex gloves
and a paper mask. Don't vacuum or sweep up the droppings; they
become dangerous when airborne." Hantavirus infection is not
contagious, and cats and dogs have not been known to contract it.
Symptoms include high fever, body aches, chills, nausea, vomiting,
and diarrhea.
(Promed 4/1/04)
USA (California) — Local
dogs diagnosed with leptospirosis
Five dogs in Marin
County have recently been diagnosed with leptospirosis, a potentially
serious bacterial disease that can be transmitted to humans,
according to Marin County health officer Dr Fred Schwartz. He
said it is endemic to many areas in California, but it is unusual
that five dogs were diagnosed with it in a two-week period. Leptospirosis
in humans can cause symptoms such as vomiting, chills, headache,
and fever. If left untreated, it can cause kidney damage, meningitis,
liver failure, respiratory distress, and in rare instances, death.
Leptospirosis is transmitted through water contaminated with infected
urine. According to a CDC report, "This may happen by swallowing
the contaminated food or water or through skin contact, especially
with mucosal surfaces, such as the eyes or nose, or with broken
skin."
A CDC report labels leptospirosis a "re-emerging infectious
disease in California." The report indicates that there were
61 human cases of the disease between 1981 and 2001. Twelve of
those cases occurred within the last five years of that period.
It also said that most of those who contracted leptospirosis did
not get it from their pets but from recreational activities in
contaminated fresh water. Schwartz said that anyone whose pet is
showing signs of the disease should contact a veterinarian. He
said that the best ways to avoid catching it from a pet are frequent
hand washing, avoiding direct contact with animal secretions, and
wearing gloves.
(Promed 4/6/04)
Panama (Veraguas) — Three cases
of hantavirus infection
The Gorgas Commemorative Institute
confirmed a third case of hantavirus infection in the Province
of Veraguas, informed Ricardo Chong, Chief of Epidemiology of
the Ministry of Health (MINSA) in the Region. Chong mentioned
that the case is a 36-year-old male resident of Rio de Jesus
District. This is the first case detected in 2004 in this region.
The confirmation of a fourth case of hantavirus infection was in
process in a female from El Cascajilloso in Arenas de Mariato. Several
species of hantavirus may be present in Panama; previously, two
hantaviruses have been isolated in Southwestern Panama: Choclo virus
and Calabazo virus. Only the former has been associated with hantavirus
pulmonary syndrome. (Promed 3/26/04)
Argentina (Buenos
Aires) — Shigellosis outbreak
Buenos
Aires Health Minister Ismael Passaglia said 31 Mar 2004 that
water contaminated with bacteria has infected some 900 people
in the Buenos Aires province district of Rojas over the past week.
Authorities explained that the outdated system which provides water
for the 26,000 residents of Rojas and the lack of maintenance caused
the outbreak. "Scientists found the bacteria, Shigella sp.
and the protozoan Giardia lamblia, which is why the water is not
safe for humans," said Passaglia. Rojas Mayor Norberto Aloe
said: "It's been a long time since the tank has been cleaned,
and a lot of the pipelines connected to the water pumps have leaks." The
outbreak began 24 Mar 2004, when five children from a private
school became ill. By 29 Mar, hundreds suffered from stomach cramps,
vomiting, diarrhea, and fever. Over 80 percent of the 900 cases
are children between the ages of 6 and 12. On 30 Mar 2004, the
army sent a portable water-processing plant to distribute to residents.
Any role that giardiasis plays in symptoms is unknown at this point,
but it is likely not to be negligible.
(Promed 4/1/04)
Brazil (Para) — Rabies
deaths following vampire bat attacks
Thirteen deaths,
possibly due to rabies, have occurred in the Amazonian town of
Portel in the state of Para (Northern Brazil). Two of these deaths
have been confirmed and the others are being studied. The rabies
transmission is thought to be from vampire bat attacks, which
are reported as being not unusual in the area. The outbreak is
apparently under control — more than 680 persons
have been vaccinated in the last few days, and the last death occurred
1 Apr 2004.
Rabies has not been adequately controlled in some areas of Brazil.
During the course of 2003, there were 17 reported and confirmed
human cases, almost all in the north (Amazonian Region) and northeast.
Rabies transmitted by dogs is rare in other areas of the country,
whereas rabies associated with vampire bat attacks on humans is
not infrequent in the Amazonian region. Such attacks usually occur
when bats are deprived of their usual source of food, such as domestic
pigs and cattle. Elsewhere (Australia, Chile, Europe, and North
America), insectivorous bats are usually associated with transmission
of rabies virus to humans.
(Promed 4/3/04)
2. UPDATES
Dengue/DHF update:
Taiwan (South)
Taiwan has so far reported 18 cases of imported
dengue fever, but no local cases. The government has activated
its dengue fever awareness mechanism, with central and local governments
joining hands to check the outbreak. The Executive Yuan's service
center in southern Taiwan urged heightened alert 6 Apr 2004 against
dengue fever and asked passengers returning from Indonesia and
Vietnam to keep tabs on their own health.
(Promed 4/8/04)
Indonesia
From 1 Jan to 4 Apr 2004 a total of
52,013 mainly hospitalized cases of dengue and 603 deaths have
been registered with the Indonesian Ministry of Health. The overall
case fatality rate this year, particularly in Jakarta, has been
lower than in previous years. Dengue occurs every year in Indonesia,
but this year the number of cases has been unusually high in at
least 12 of 32 provinces of the country. Compared with the same
period in 2003, the number of cases has doubled.
The Ministry of Health has set up rapid response and surveillance
teams to update and analyze the data from all provinces to guide
appropriate action. The national government is providing free hospital
care to those patients presenting with symptoms of dengue and without
adequate financial resources. The local health authorities are
conducting intensive vector control activities and are mobilizing
the communities to eliminate unwanted containers in which the mosquitoes
breed. WHO is assisting the Ministry of Health with laboratory
diagnosis.
(Promed 4/8/04)
Bangladesh
Dengue threatens to strike Dhaka
off guard as the health ministry, health department, and Dhaka
City Corporation (DCC) are in apparent inaction to fight a repeat
of the deadly outbreak that killed 193 people on record since 2000.
About 12,000 people have been infected and hospitalized since 2000,
the year dengue struck Bangladesh for the first time; 136 people
died of dengue in 2000, 36 in 2001, and 21 in 2002 in Dhaka. How
many people died last year is not known. Dengue, which usually
breaks out in May and rages full-blown for the next three months,
is still a major threat to public health but has been ignored over
the last two years. The DCC has no surveillance and runs short
of adulticide and larvicide to spray in city wards.
(Promed 4/8/04)
Cholera, diarrhea Update:
India (New Delhi) — Cholera
The
number of cholera cases reported in the city has risen to 21 since
Jan 2004 according to Municipal Corporation of Delhi (MCD) records.
This year, the number of cases in March 2004 was 15 as compared
to five cases in March 2002. No cases were reported in March during
2003. The highest number of cases is in the central zone, which
has reported 11 cases. The incidence of cholera rises during the
monsoon when dirty water collects around shallow hand-pumps. (Promed 4/3/04)
Indonesia (Maluku)—Diarrhea
At
least five people have died of diarrhea, and more than 40 have
been treated by central health office following an outbreak of
the disease in Indonesia's Maluku province, a local health official
told ASEAN-Disease-Surveillance.net 1 Apr 2004. The official said
the outbreak hit the village of Amarlaut, Gorom Sub-district of
Seram Bagian Timur Regency, Maluku beginning in early March 2004.
The village has about 1000 residents, and most of them have difficulties
finding clean water. This critical situation put them at risk for
the disease; local health agencies have sent medicine and medical
officers to support treatment in the area.
(Promed 4/3/04)
Update: Influenza Activity —- United
States, 2003—04 Season
A summary
of influenza activity in the United States during September 29,
2003 — March 27, 2004 is now available through CDC’s
MMWR report. This report also summarizes human infections with
avian influenza viruses related to poultry outbreaks in North America.
Preliminary data collected through CDC influenza surveillance
indicate that national influenza activity peaked during late November
– December. The most frequently isolated viruses were influenza
A (H3N2), and approximately 87% of these were similar to the
drift variant A/Fujian/411/2002.
http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5313a2.htm
(MMWR April
9, 2004 / 53(13);284-287)
4. ARTICLES
Progress Toward Poliomyelitis Eradication —- India,
2003
“Since the World Health Assembly resolved in
May 1988 to eradicate poliomyelitis, the estimated global incidence
of polio has decreased >99%, and three World Health Organization
(WHO) regions (Americas, Western Pacific, and European) have been
certified as polio-free. Since 1994, when the countries of the WHO
South-East Asia Region (SEAR) began accelerating polio-eradication
activities, substantial progress toward that goal has been made.
By 2001, poliovirus circulation in India had been limited primarily
to the two northern states of Uttar Pradesh and Bihar, with 268 cases
reported nationwide. However, a major resurgence of polio occurred
during 2002, with 1,600 cases detected nationwide, of which 1,363
(85%) were in Uttar Pradesh and Bihar. This report summarizes the
status of polio eradication activities in India during 2003 and describes
the actions being taken to reduce poliovirus transmission.”
http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5311a3.htm
(MMWR March
26, 2004 / 53(11);238-241)
Imported measles case associated
with nonmedical vaccine exemption — Iowa,
March 2004
“On March 13, 2004, the Iowa Department
of Public Health (IDPH) reported to CDC that a male student aged
19 years with measles in the infectious stage had flown from
New Delhi, India, to Cedar Rapids, Iowa, on March 12. Because
of a nonmedical exemption, the student had not received measles-containing
vaccine (MCV). This report describes the measles case, the public
health response to prevent secondary cases, and the impact on
the public health system. Health-care providers and state and
local public health departments should be alert to possible cases
of measles in persons who traveled with this student or their
contacts. Parents considering nonmedical exemptions for their
children should be aware of the potential risk for disease both
for their children and the public.”
http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5311a6.htm
(MMWR March
26, 2004 / 53(11);244-246)
Multistate investigation of measles among adoptees from China —-
April 2004
“On April 6, 2004, Public Health —
Seattle and King County, Washington, reported a laboratory-confirmed
case of measles in a recently adopted child from China. Public
health authorities in Washington state notified CDC, which collaborated
with health officials in other states to locate other recently
adopted children from China and contact their adoptive families.
This report summarizes the preliminary results of an ongoing
multistate investigation that has so far identified four confirmed
and five suspected cases of measles among adoptees from China,
underscoring the need for health-care providers to remain vigilant
for measles and other vaccine-preventable communicable diseases
in children adopted from international regions.”
http://www.cdc.gov/mmwr/preview/mmwrhtml/mm53d409a1.htm
(MMWR
April 9, 2004 / 53(Dispatch);1-2)
Update: West Nile Virus
Screening of Blood Donations and Transfusion-Associated Transmission
—- United States, 2003
“In
2002, transfusion-associated transmission (TAT) of West Nile
virus (WNV) infection acquired through blood transfusion marked
the emergence of a new threat to the U.S. blood supply. Although
mosquito-borne transmission remains the predominant mode of WNV
transmission, identification of TAT underscored the need for
WNV screening of donated blood. In June 2003, blood-collection
agencies (BCAs) implemented investigational WNV nucleic acid — amplification
tests (NATs) to screen all blood donations and identify potentially
infectious donations for quarantine and retrieval. This screening
was performed on approximately 6 million units during June — December
2003, resulting in the removal of at least 818 viremic blood donations
from the blood supply. This report summarizes the results of blood-donation
screening tests conducted during 2003 and describes six cases of
WNV TAT that occurred because of transfusion of components containing
low levels of virus not detected by the testing algorithm. These
data indicate that blood screening for WNV has improved blood safety.
However, a small risk of WNV transfusion-associated transmission
remains. To address this risk, changes to screening strategies
are planned for 2004.”
http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5313a1.htm
(MMWR
April 9, 2004 / 53(13);281-284)
Osteomyelitis/Septic Arthritis Caused by Kingella
kingae Among Day Care Attendees —- Minnesota, 2003
“Kingella
kingae is a fastidious gram-negative
coccobacillus that colonizes the respiratory and oropharyngeal
tract in children. K. kingae occasionally causes invasive
disease, primarily osteomyelitis/septic arthritis in young children,
bacteremia in infants, and endocarditis in school-aged children
and adults. Although diagnosis of this organism frequently is missed,
invasive disease is uncommon. Only sporadic, non-epidemiologically
linked cases have been reported previously. In October 2003, the
Minnesota Department of Health (MDH) investigated a cluster of
two confirmed cases and one probable case of osteomyelitis/septic
arthritis caused by K. kingae among children aged 17–21
months attending the same toddler classroom in a daycare center.
All reported within the same week with onset of fever, preceding
or concurrent upper respiratory illness (URI), and refusal to bear
weight on the affected limb. This report summarizes these cases
and describes the epidemiologic investigation of the day care center.
The findings underscore the need for clinicians and laboratorians
to consider K. kingae infection in young children with
Gram stain — negative or culture-negative skeletal infections.”
http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5311a4.htm
(MMWR March
26, 2004 / 53(11);241-243)
WHO sees surge in progress against tuberculosis; health,
finance ministers meet in New Delhi on
challenge of treating an additional one million patients a year
The
number of tuberculosis patients diagnosed and treated under DOTS,
the internationally recommended strategy for TB control, is now
rising much faster than at any time since DOTS expansion began
in 1995, according to a new report by the WHO. The 2004 Global
Tuberculosis Control report confirms that DOTS programmes are now
treating three million TB patients every year, an increase of more
than one million patients compared to just two years ago. That
increase is nearly double the average annual increment of 270,000
patients during the previous six-year period, and the trajectory
is still heading upward. India is leading the surge, followed by
smaller but significant increases in five other key countries with
high rates of TB: South Africa, Indonesia, Pakistan, Bangladesh
and the Philippines.
"DOTS expansion is one of the major public health success
stories of the past decade, one that is saving thousands more lives
every day," Dr. Lee Jong-wook, WHO Director-General, said. "But
to reach the 2005 targets for detection and treatment, the challenge
now is to add another one million TB patients to DOTS programs
each year. Many of these new cases will be recruited from the hospitals
and private health sector in Asia, especially China, and from
beyond the present limits of health systems in Africa."The
global 2005 targets for TB control are to detect 70% of all infectious
TB cases and cure 85% of those cases detected. According to the
WHO report, the case detection rate has risen to 37% and cure rates
to 82%. Meeting the 2005 targets will put the world's TB control
programmes on the path to achieving the Millennium Development
Goal (MDG) of halving the global TB burden by 2015. Expanding and
strengthening DOTS is key to halting the spread of TB because it
is cost-effective, ensures treatment compliance, and prevents the
development of drug-resistant strains of TB. The World Bank, a
key member of the Stop TB Partnership and a leading financier of
TB-related programmes in developing countries, welcomed the WHO
report as evidence that donor funding for expanding DOTS treatment
had proven effective in improving the health and welfare of communities
afflicted by the disease.
There are an estimated 8.8 million new cases of TB each year
of which 3.9 million are infectious. The number of new cases is
increasing rapidly in Eastern Europe, mainly countries of the
former Soviet Unio, which only recently started to implement DOTS.
TB incidence rates also continue to rise at an alarming rate in
African countries with high HIV prevalence. "HIV/AIDS is driving
the TB epidemic in southern and eastern Africa and will worsen
the situation in Eastern Europe, India and China in the years
ahead," said Dr Jack Chow, the WHO Assistant Director-General
for HIV/AIDS, Tuberculosis and Malaria. "We cannot control
one without controlling the other, and must begin rapidly scaling
up TB/HIV collaborative activities to provide a synergy of prevention,
treatment and care for co-infected patients."
(WHO 3/23/04)
WHO leads drive for international coordination of clinical
research
The WHO and Current Controlled Trials (CCT)
have announced that all randomized controlled trials approved
by the WHO ethics review board will be assigned an International
Standard Randomised Controlled Trial Number (ISRCTN). As a result,
the scientific community should now find it easier to keep up-to-date
with current research. Randomised controlled trials are considered
the best way to compare — in an unbiased manner — the effects
of particular interventions on people or populations either for
health promotion, prevention, treatment or for rehabilitation.
However, information about these trials is difficult to find,
because several trials may have the same title, one trial may
be reported in several places under different titles, and many
trials are never reported at all.
Information is even more difficult to find about neglected diseases
that disproportionately affect poor and marginalized populations.
WHO supports and funds much of the research in this area. However;
so far, there has been no mechanism to make the information generated
from this research easily available to researchers, particularly
those in developing countries whom it affects most. By providing
free access on the internet, ISRCTNs offer a way to keep the international
community informed about these clinical trials. Randomised trials
in the other major research areas that the WHO supports — infectious
diseases, childhood diseases, vaccines and others will be added
shortly to the ISRCTN Register. The Register also tackles the problem
of publication bias — trials that are not published either because
of negative findings, or language barriers, or inaccessibility
of the researcher to journals. By registering clinical trials at
the start of the research, the ISRCTN Register will ensure that
this information is now more easily available.
The ISRCTN Register is the first online service that provides
unique numbers to randomised controlled trials in all areas of
health care and from all countries around the world. Access to
the ISRCTN Register is free and open to the public. Since its launch
in May 2003, the Register has assigned ISRCTNs to over 1800 trials,
and is growing fast. The ISRCTN Register has been developed by
Current Controlled Trials Ltd, part of the Current Science Group
of companies.
(WHO 4/2/04)
Human and avian influenza viruses target different cell
types in cultures of human airway epithelium
Mikhail
N. Matrosovich, Tatyana Y. Matrosovich, Thomas Gray, Noel A.
Roberts, and Hans-Dieter Klenk.
http://www.pnas.org/cgi/content/abstract/101/13/4620?etoc
"The recent human infections caused by H5N1, H9N2, and H7N7
avian influenza viruses highlighted the continuous threat of new
pathogenic influenza viruses emerging from a natural reservoir
in birds. It is generally believed that replication of avian influenza
viruses in humans is restricted by a poor fit of these viruses
to cellular receptors and extracellular inhibitors in the human
respiratory tract. However, detailed mechanisms of this restriction
remain obscure. Using cultures of differentiated human airway epithelial
cells, we demonstrated that influenza viruses enter the airway
epithelium through specific target cells and that there were striking
differences in this respect between human and avian viruses. During
the course of a single-cycle infection, human viruses preferentially
infected non-ciliated cells, whereas avian viruses, as well as
the egg-adapted human virus variant with an avian virus-like receptor
specificity, mainly infected ciliated cells. This pattern correlated
with the predominant localization of receptors for human viruses
(2-6-linked sialic acids) on non-ciliated cells and of receptors
for avian viruses (2-3-linked sialic acids) on ciliated cells.
These findings suggest that although avian influenza viruses can
infect human airway epithelium, their replication may be limited
by a non-optimal cellular tropism. Our data throw light on the
mechanisms of generation of pandemic viruses from their avian progenitors
and open avenues for cell level-oriented studies on the replication
and pathogenicity of influenza virus in humans."
(Promed 3/31/04)
4. NOTIFICATIONS
PAHO: Vaccination Week in the Americas
Coordinated by WHO's Regional Office for the Americas (PAHO), from April 24 to
30, countries from Canada to the tip of South America and throughout the Caribbean
will be part of an unprecedented “Vaccination Week in the Americas”.
Targeting 40 million people, the beneficiaries will be children, young women,
and seniors, mostly in remote areas. Participating countries will vaccinate
against diseases such as measles, polio and rubella.
http://www.paho.org/English/DD/PIN/sv_2004.htm
(WHO,
PAHO)
53rd Annual Epidemic Intelligence Service
(EIS) Conference
April 19-23, 2004; Atlanta, GA
EIS is the country's critical
epidemiology training service, combating the causes of major epidemics.
Over the past 50 years, EIS officers have played pivotal roles in
combating the root causes of major epidemics. The primary purpose
of the EIS Conference is to provide current EIS officers a training
experience for making scientific presentations. Additional purposes
include: 1) providing an opportunity for scientific exchange regarding
current epidemiologic topics; 2) highlighting the breadth of epidemiologic
activities at CDC; 3) providing a setting for strengthening the EIS
professional network among new, current, and former EIS officers;
and 4) providing a forum for CDC programs to recruit new EIS officers.
http://www.cdc.gov/eis/conference/conference.htm
(CDC)
Guidelines for preventing healthcare–associated
pneumonia, 2003: Recommendations of CDC and the Healthcare Infection
Control Practices Advisory Committee
This report updates,
expands, and replaces the previously published CDC "Guideline
for Prevention of Nosocomial Pneumonia".
The new guidelines are designed to reduce the incidence of pneumonia
and other severe, acute lower respiratory tract infections in acute-care
hospitals and in other health-care settings (e.g., ambulatory and
long-term care institutions) and other facilities where health
care is provided.
http://www.cdc.gov/mmwr/preview/mmwrhtml/rr5303a1.htm
(MMWR
March 26, 2004 / 53(RR03);1-36)
GIDEON: Infectious Disease and Epidemiology database
The
University of Washington library http://healthlinks.washington.edu/ is offering the GIDEON, Infectious Disease and Epidemiology database
on a trial basis and looking for feedback. GIDEON diagnoses Infectious
Disease (see Avian Flu diagnosis http://www.gideononline.com/avianflu.htm)
and provides up-to-date Epidemiology data including emerging infections
like Avian Influenza. GIDEON provides complete anti-infective drug
and vaccine treatment and pathogen information. The University
is deciding now whether to offer this resource. If you or your
colleagues can benefit from access, please email Nanette Welton, nwelton@u.washington.edu.
If you have any questions, please contact Adrienne Rutledge of
GIDEON at: Tel: 1-888-644-3366 or 1-510-430-9594 or email: rutledge@GIDEONonline.com.